Scott G Weiner1, Olesya Baker2, Dana Bernson3, Jeremiah D Schuur4. 1. Brigham and Women's Hospital, Boston, MA. Electronic address: sweiner@bwh.harvard.edu. 2. Brigham and Women's Hospital, Boston, MA. 3. Massachusetts Department of Public Health, Boston, MA. 4. Alpert Medical School, Brown University, Providence, RI.
Abstract
STUDY OBJECTIVE: Despite the increased availability of naloxone, death rates from opioid overdose continue to increase. The goal of this study is to determine the 1-year mortality of patients who were treated for a nonfatal opioid overdose in Massachusetts emergency departments (EDs). METHODS: This was a retrospective observational study of patients from 3 linked statewide Massachusetts data sets: a master demographics list, an acute care hospital case-mix database, and death records. Patients discharged from the ED with a final diagnosis of opioid overdose were included. The primary outcome measure was death from any cause within 1 year of overdose treatment. RESULTS: During the study period, 17,241 patients were treated for opioid overdose. Of the 11,557 patients who met study criteria, 635 (5.5%) died within 1 year, 130 (1.1%) died within 1 month, and 29 (0.25%) died within 2 days. Of the 635 deaths at 1 year, 130 (20.5%) occurred within 1 month and 29 (4.6%) occurred within 2 days. CONCLUSION: The short-term and 1-year mortality of patients treated in the ED for nonfatal opioid overdose is high. The first month, and particularly the first 2 days after overdose, is the highest-risk period. Patients who survive opioid overdose should be considered high risk and receive interventions such as being offered buprenorphine, counseling, and referral to treatment before ED discharge.
STUDY OBJECTIVE: Despite the increased availability of naloxone, death rates from opioid overdose continue to increase. The goal of this study is to determine the 1-year mortality of patients who were treated for a nonfatal opioid overdose in Massachusetts emergency departments (EDs). METHODS: This was a retrospective observational study of patients from 3 linked statewide Massachusetts data sets: a master demographics list, an acute care hospital case-mix database, and death records. Patients discharged from the ED with a final diagnosis of opioid overdose were included. The primary outcome measure was death from any cause within 1 year of overdose treatment. RESULTS: During the study period, 17,241 patients were treated for opioid overdose. Of the 11,557 patients who met study criteria, 635 (5.5%) died within 1 year, 130 (1.1%) died within 1 month, and 29 (0.25%) died within 2 days. Of the 635 deaths at 1 year, 130 (20.5%) occurred within 1 month and 29 (4.6%) occurred within 2 days. CONCLUSION: The short-term and 1-year mortality of patients treated in the ED for nonfatal opioid overdose is high. The first month, and particularly the first 2 days after overdose, is the highest-risk period. Patients who survive opioid overdose should be considered high risk and receive interventions such as being offered buprenorphine, counseling, and referral to treatment before ED discharge.
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Alana M Vivolo-Kantor; Puja Seth; R Matthew Gladden; Christine L Mattson; Grant T Baldwin; Aaron Kite-Powell; Michael A Coletta Journal: MMWR Morb Mortal Wkly Rep Date: 2018-03-09 Impact factor: 17.586
Authors: Scott G Weiner; Rebecca E Cash; Michelle Hendricks; Sanae El Ibrahimi; Olesya Baker; Raghu R Seethala; Gregory Peters; Scott A Goldberg Journal: Prehosp Emerg Care Date: 2020-12-15 Impact factor: 3.077
Authors: Charles P France; Gerard P Ahern; Saadyah Averick; Alex Disney; Heather A Enright; Babak Esmaeli-Azad; Arianna Federico; Lisa R Gerak; Stephen M Husbands; Benedict Kolber; Edmond Y Lau; Victoria Lao; David R Maguire; Michael A Malfatti; Girardo Martinez; Brian P Mayer; Marco Pravetoni; Niaz Sahibzada; Phil Skolnick; Evan Y Snyder; Nestor Tomycz; Carlos A Valdez; Jim Zapf Journal: Clin Pharmacol Ther Date: 2020-11-29 Impact factor: 6.875
Authors: Mary Funke; Marcus C Kaplan; Holly Glover; Nicole Schramm-Sapyta; Andrew Muzyk; Jennifer Mando-Vandrick; Alexander Gordee; Maragatha Kuchibhatla; Emily Sterrett; Stephanie A Eucker Journal: Jt Comm J Qual Patient Saf Date: 2021-03-06
Authors: Kathryn Hawk; Lauretta E Grau; David A Fiellin; Marek Chawarski; Patrick G O'Connor; Nikolas Cirillo; Chris Breen; Gail D'Onofrio Journal: Acad Emerg Med Date: 2021-02-28 Impact factor: 3.451
Authors: Jingchuan Guo; Wei-Hsuan Lo-Ciganic; Qingnan Yang; James L Huang; Jeremy C Weiss; Gerald Cochran; Daniel C Malone; Courtney C Kuza; Adam J Gordon; Julie M Donohue; Walid F Gellad Journal: J Gen Intern Med Date: 2021-01-22 Impact factor: 5.128
Authors: Elizabeth M Schoenfeld; William E Soares; Emily M Schaeffer; Jacob Gitlin; Kimberly Burke; Lauren M Westafer Journal: Acad Emerg Med Date: 2021-09-07 Impact factor: 3.451